Tourmaline Bio, Inc. - TRML Revenue Change YoY (Last 12 Months)

The LTM sales growth rate on GURU.Markets shows that the value has stabilized at , reflecting Tourmaline Bio, Inc. (TRML) dependence on cash reserves due to a current lack of revenue. Geopolitical risks remain minimal, as patents are protected under Western law. The leadership's strong scientific potential and the transparency of test data create a powerful foundation for future commercialization.
Summary analytical data breakdowns for Tourmaline Bio Inc (TRML)

For Tourmaline Bio, Inc. (TRML), which is currently in the clinical expansion stage of its immunology portfolio, the trailing twelve-month revenue growth chart serves as an indicator of commercial scaling. This metric calculates the percentage increase in sales over a rolling twelve-month period, allowing investors to assess the real-time dynamics of business expansion and determine whether a temporary slowdown in growth rates results from cost optimization or market stagnation.